Priority Date: 21.04.08 (EP 20080103629)

Hyperglycosylated human coagulation factor IX

  • Application ID: EP14164727
  • Status: APPLICATION WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 172 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 21.04.2008 - Priority Date (EP 20080103629)
  • 10.12.2014 - Publication A2 (EP2811017)

IPC Classification